Cholangiocarcinoma historical perspective: Difference between revisions

Jump to navigation Jump to search
Line 24: Line 24:
==Landmark Events in the Development of Treatment Strategies==
==Landmark Events in the Development of Treatment Strategies==
*In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].
*In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].
==Impact on Cultural History==


==Famous Cases==
==Famous Cases==

Revision as of 14:22, 6 February 2018

Cholangiocarcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholangiocarcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholangiocarcinoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholangiocarcinoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholangiocarcinoma historical perspective

CDC on Cholangiocarcinoma historical perspective

Cholangiocarcinoma historical perspective in the news

Blogs on Cholangiocarcinoma historical perspective

Directions to Hospitals Treating Cholangiocarcinoma

Risk calculators and risk factors for Cholangiocarcinoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

Historical Perspective

Discovery

  • [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
  • The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
  • In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
  • In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].

Dimensional-differential gel electrophoresis couple with liquid chromatography tandem mass spectrometry (2D-DIGE/LC-MS-MS) Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF-MS) Surface enhanced laser desorption/ionization (SELDI)-TOF-MS Capillary electrophoresis (CE)-MS

  • In 1973, 64 years old man was first case of primary intrahepatic cholangiocarcinoma with right upper quadrant pain, jaundice, and weight loss.[1]

Landmark Events in the Development of Treatment Strategies

  • In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].

Famous Cases

References

  1. Lubana SS, Singh N, Seligman B, Tuli SS, Heimann DM (2015). "First Reported Case of Primary Intrahepatic Cholangiocarcinoma with Pure Squamous Cell Histology: A Case Report". Am J Case Rep. 16: 438–44. doi:10.12659/AJCR.894609. PMC 4501643. PMID 26158884.

Template:WH Template:WS